PrintThe Burrill Report (December 13, 2010): Kindler Out, Read In at Pfizer (.MP3,8.86 Mb)
Jeff Kindler’s sudden retirement as CEO of the drug giant Pfizer stunned the industry. Kindler leaves Pfizer at a critical time for the company as it braces for the loss of billions in revenue as patent protection expires on its best-selling drug Lipitor among others. Ian Read, group president of the worldwide biopharmaceutical business, has taken over the post of CEO. We spoke to Adam Feuerstein, senior columnist for TheStreet.com about Kindler’s departure, the selection of Read, and what it will take to make Pfizer the envy of the industry once again.
December 10, 2010
http://www.burrillreport.com/article-kindler_out_read_in_at_pfizer.html
.gif)
.gif)
